Cargando…
Oral nano-formulation improves pancreatic islets dysfunction via lymphatic transport for antidiabetic treatment
Type 2 diabetes mellitus (T2DM) therapy is facing the challenges of long-term medication and gradual destruction of pancreatic islet β-cells. Therefore, it is timely to develop oral prolonged action formulations to improve compliance, while restoring β-cells survival and function. Herein, we designe...
Autores principales: | Hou, Lin, Peng, Xueyuan, Wang, Ruiting, Wang, Yifei, Li, Hong, Zhang, Huijuan, Zhang, Yun, Zhang, Zhenzhong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10373096/ https://www.ncbi.nlm.nih.gov/pubmed/37521855 http://dx.doi.org/10.1016/j.apsb.2022.12.014 |
Ejemplares similares
-
Glucose transporters in pancreatic islets
por: Berger, Constantin, et al.
Publicado: (2020) -
An in situ microenvironmental nano-regulator to inhibit the proliferation and metastasis of 4T1 tumor
por: Zhang, Huijuan, et al.
Publicado: (2019) -
Islet cell dysfunction in patients with chronic pancreatitis
por: Roy, Ayan, et al.
Publicado: (2020) -
Drug Transport Mechanism of Oral Antidiabetic Nanomedicines
por: Gundogdu, Evren, et al.
Publicado: (2014) -
Bioactivity and antidiabetic properties of Malva parviflora L. leaves extract and its nano-formulation in streptozotocin-induced diabetic rats
por: Mohammed, Dina Mostafa, et al.
Publicado: (2022)